William Blair & Company’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-187,900
| Closed | -$639K | – | 1828 |
|
|
2018
Q3 | $639K | Sell |
187,900
-7,000
| -4% | -$23.8K | ﹤0.01% | 875 |
|
|
2018
Q2 | $733K | Buy |
194,900
+6,800
| +4% | +$25.6K | 0.01% | 820 |
|
|
2018
Q1 | $769K | Hold |
188,100
| – | – | 0.01% | 779 |
|
|
2017
Q4 | $875K | Sell |
188,100
-4,300
| -2% | -$20K | 0.01% | 779 |
|
|
2017
Q3 | $1.37M | Buy |
192,400
+51,200
| +36% | +$364K | 0.01% | 642 |
|
|
2017
Q2 | $1.02M | Buy |
+141,200
| New | +$1.02M | 0.01% | 747 |
|
|
2015
Q1 | – | Sell |
-9,000
| Closed | -$127K | – | 2215 |
|
|
2014
Q4 | $127K | Buy |
+9,000
| New | +$127K | ﹤0.01% | 2004 |
|
|
2014
Q1 | – | Sell |
-7,400
| Closed | -$95K | – | 2074 |
|
|
2013
Q4 | $95K | Buy |
7,400
+200
| +3% | +$2.57K | ﹤0.01% | 1914 |
|
|
2013
Q3 | $72K | Buy |
+7,200
| New | +$72K | ﹤0.01% | 1970 |
|